IP Verse

Gillard competitive analysis

Loading summary...

Explore patent oppositions filed by Gillard against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3395339	Rapid Dissolution Formulation Of A Cinacalcet Hcl	AMGEN	Jan 16, 2020
EP3395340	Rapid Dissolution Formulation Of Cinacalcet Hcl	AMGEN	Jan 16, 2020
EP1633766	Modified Fluorinated Nucleoside Analogues	GILEAD PHARMASSET	Dec 5, 2019
EP2981271	Therapeutic Uses Of Empagliflozin	BOEHRINGER INGELHEIM	Aug 14, 2019
EP3004388	Detection And Quantification Of Donor Cell-Free Dna In The Circulation Of Organ Transplant Recipients	CHRONIX BIOMEDICAL	Jul 31, 2019
EP2709613	Methods For Treating Hcv	GILEAD PHARMASSET	Aug 22, 2018
EP2822777	Multi-Layer Printing Process	AMCOR GROUP	Jul 11, 2018

Explore the latest publications and patents granted to Gillard, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Gillard, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Gillard with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GILLARD	7	-	-	-
AMGEN	8	138	8	11
BOEHRINGER INGELHEIM	3	142	2	1
GILEAD PHARMASSET	-	2	-	10